GLP-1 RAs and Substance Use Disorder Treatment: The Potential and Emerging Challenges
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are revolutionizing the management of type 2 diabetes and obesity. Exciting new research suggests these medications may also hold immense promise for treating substance use...
      
 
 
 
 
 
 
 
